IP Library › Granted Patent US 10,335,514
Granted Patent B2
US 10,335,514 · App. 15/472,855 · Granted Jul 2, 2019

Composition, cell structure, pancreatic islet transplantation kit, pancreatic islet cell transplantation treatment agent and hypoglycemic agent, composition containing pancreatic islet, kit containing pancreatic islet, and pancreatic islet transplantation treatment agent and hypoglycemic agent

Inventors: Reiko Iwazawa (Ashigarakami-gun, JP); Kentaro Nakamura (Ashigarakami-gun, JP)
Assignee: FUJIFILM Corporation
A61L27/3804A61K9/16A61K35/12A61K35/39A61K47/42A61L27/00A61L27/222A61L27/3886A61L27/56A61L2300/64A61L2430/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,335,514
App. No.
15/472,855
Granted
Jul 2, 2019
Kind
B2
Abstract

An object is to provide a composition containing a pancreatic islet, a cell structure containing a pancreatic islet or a pancreatic islet cell, a pancreatic islet transplantation kit, a pancreatic islet transplantation treatment agent, and a hypoglycemic agent which improve at least one of glucose sensitivity or blood sugar level-reducing performance after transplantation, and to provide a composition containing a pancreatic islet, a kit containing a pancreatic islet, a pancreatic islet cell transplantation treatment agent, and a hypoglycemic agent which can improve glucose sensitivity. A composition including (A): a cell structure containing a biocompatible macromolecular block and at least one kind of cell and in which a plurality of the above-described macromolecular blocks are arranged in gaps between a plurality of the above-described cells; and (B): a pancreatic islet, and a composition containing a pancreatic islet; and a spheroid formed of at least one type of stem cell are provided.

Claims (26)

1. A composition comprising:

(A): a cell structure which contains a biocompatible macromolecular block and at least one kind of cell and in which a plurality of the macromolecular blocks are arranged in gaps between a plurality of the cells; and

(B): a pancreatic islet,

wherein said biocompatible macromolecular block is a polypeptide, and said at least one kind of cell comprises a mesenchymal stem cell, and said pancreatic islet is an aggregate of a α cell, a β cell, a δ cell, a ε cell and a PP cell.

2. The composition according to claim 1 ,

wherein the thickness or the diameter of the cell structure is 100 μm to 3 cm.

3. The composition according to claim 1 ,

wherein the biocompatible macromolecular block is formed of a recombinant peptide.

4. A cell structure comprising:

a biocompatible macromolecular block;

at least one kind of cell; and

a pancreatic islet,

wherein a plurality of the macromolecular blocks are arranged in gaps between a plurality of the cells,

wherein said biocompatible macromolecular block is a polypeptide, said at least one kind of cell comprises a mesenchymal stem cell, and said pancreatic islet is an aggregate of a α cell, a β cell, a δ cell, ε cell and a PP cell.

5. The cell structure according to claim 4 ,

wherein SI, which is an amount of insulin during culture in 20 mM glucose medium/amount of insulin during culture in 3 mM glucose medium, is greater than or equal to 3.0.

6. The cell structure according to claim 4 ,

wherein the biocompatible macromolecular block is a recombinant peptide.

7. A pancreatic islet transplantation kit, comprising:

A): a cell structure which contains a biocompatible macromolecular block and at least one kind of cell and in which a plurality of the macromolecular blocks are arranged in gaps between a plurality of the cells; and

(B): a pancreatic islet,

wherein said biocompatible macromolecular block is a polypeptide, and said at least one kind of cell comprises a mesenchymal stem cell, and said pancreatic islet is an aggregate of a α cell, a β cell, a δ cell, a ε cell and a PP cell.

8. The pancreatic islet transplantation kit according to claim 7 ,

wherein the thickness or the diameter of the cell structure is 100 μm to 3 cm.

9. The pancreatic islet transplantation kit according to claim 7 ,

wherein the biocompatible macromolecular block is formed of a recombinant peptide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2017
From: IWAZAWA, REIKO; NAKAMURA, KENTARO
To: FUJIFILM CORPORATION
Reel/Frame 041787/0892 →
Priority Claims (4)
JP 2014-200220 · Sep 30, 2014 · national
JP 2014-262637 · Dec 25, 2014 · national
JP 2014-262662 · Dec 25, 2014 · national
JP 2015-030398 · Feb 19, 2015 · national
Continuity (2)
Continuation PCTJP2015077516 · Sep 29, 2015
Related Publication 20170203005A1 · Jul 20, 2017
Cited By (2)
US 12,194,138 US 12,630,795